The NFκB molecular cluster in newly diagnosed MM patients included in dataset GSE19784 (Figure 1C) also showed a significantly higher expression of BCL2A1, compared to three out of five additional molecular clusters that did not have a significantly increased NFκB activity score (Figure 4B). This evidence concerns the gene BCL2A1 and Miyoshi myopathy.